Single User License
INR 96420
Site License
INR 192840
Corporate User License
INR 289260

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Crescendo Biologics Limited-Product Pipeline Review-2015

Crescendo Biologics Limited-Product Pipeline Review-2015

  • Products Id :- GMDHC07042CDB
  • |
  • Pages: 21
  • |
  • April 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Crescendo Biologics Limited-Product Pipeline Review-2015


Global Markets Direct's, 'Crescendo Biologics Limited-Product Pipeline Review-2015', provides an overview of the Crescendo Biologics Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Crescendo Biologics Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Crescendo Biologics Limited including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Crescendo Biologics Limited's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Crescendo Biologics Limited's pipeline products

Reasons To Buy

Evaluate Crescendo Biologics Limited's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Crescendo Biologics Limited in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Crescendo Biologics Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Crescendo Biologics Limited and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Crescendo Biologics Limited

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Crescendo Biologics Limited and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Crescendo Biologics Limited Snapshot 4

Crescendo Biologics Limited Overview 4

Key Information 4

Key Facts 4

Crescendo Biologics Limited-Research and Development Overview 5

Key Therapeutic Areas 5

Crescendo Biologics Limited-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Crescendo Biologics Limited-Pipeline Products Glance 9

Crescendo Biologics Limited-Early Stage Pipeline Products 9

Preclinical Products/Combination Treatment Modalities 9

Discovery Products/Combination Treatment Modalities 10

Crescendo Biologics Limited-Drug Profiles 11

CB-001 11

Product Description 11

Mechanism of Action 11

R&D Progress 11

Monoclonal Antibodies to Agonize CD3 and to Target TsA for Prostate Cancer 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

Monoclonal Antibodies to Antagonize CD3 for Cancer 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

Monoclonal Antibody Conjugates for Cancer 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Crescendo Biologics Limited-Pipeline Analysis 15

Crescendo Biologics Limited-Pipeline Products by Target 15

Crescendo Biologics Limited-Pipeline Products by Route of Administration 16

Crescendo Biologics Limited-Pipeline Products by Molecule Type 17

Crescendo Biologics Limited-Pipeline Products by Mechanism of Action 18

Crescendo Biologics Limited-Locations And Subsidiaries 19

Head Office 19

Appendix 20

Methodology 20

Coverage 20

Secondary Research 20

Primary Research 20

Expert Panel Validation 20

Contact Us 20

Disclaimer 21

List of Tables

Crescendo Biologics Limited, Key Information 4

Crescendo Biologics Limited, Key Facts 4

Crescendo Biologics Limited-Pipeline by Indication, 2015 6

Crescendo Biologics Limited-Pipeline by Stage of Development, 2015 7

Crescendo Biologics Limited-Monotherapy Products in Pipeline, 2015 8

Crescendo Biologics Limited-Preclinical, 2015 9

Crescendo Biologics Limited-Discovery, 2015 10

Crescendo Biologics Limited-Pipeline by Target, 2015 15

Crescendo Biologics Limited-Pipeline by Route of Administration, 2015 16

Crescendo Biologics Limited-Pipeline by Molecule Type, 2015 17

Crescendo Biologics Limited-Pipeline Products by Mechanism of Action, 2015 18

List of Figures

Crescendo Biologics Limited-Pipeline by Top 10 Indication, 2015 6

Crescendo Biologics Limited-Pipeline by Stage of Development, 2015 7

Crescendo Biologics Limited-Monotherapy Products in Pipeline, 2015 8

Crescendo Biologics Limited-Pipeline by Top 10 Molecule Type, 2015 17

Crescendo Biologics Limited-Pipeline Products by Top 10 Mechanism of Action, 2015 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Crescendo Biologics Limited; Crescendo Biologics Limited - Key Therapeutics; Crescendo Biologics Limited - Pipeline Overview and Promising Molecules; Crescendo Biologics Limited - News; Crescendo Biologics Limited - Latest Updates; Crescendo Biologics Limited - Pipeline; Crescendo Biologics Limited - Discontinued/Dormant Projects

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]